SlideShare uma empresa Scribd logo
1 de 27
Vascular Access for CRRT
Timothy E Bunchman
Professor & Director
Helen DeVos Children’s Hospital
Grand Rapids, MI
(Thanks to Rick Hackbarth MD for his help
and slides)
Access
 If you don’t have it you might as well go
home.
 This is the most important aspect of CRRT
therapy.
 Adequacy.
 Filter life.
 Increased blood loss.
 Staff satisfaction.
Vascular Access
 Ideal Catheter Characteristics
 Easy Insertion
 Permits Adequate Blood Flow without Vessel Damage
 Minimal Technical Flaws
 High Recirculation Rate
 Kinking
 Shorter and Larger Catheters
SIZE DOES MATTER
 Lower Resistance
 Improved Bloodflow
Vascular Access for CRRT
 Match catheter size to patient size and
anatomical site
 One dual- or triple-lumen or two single lumen
uncuffed catheters
 Sites
 femoral
 internal jugular
 avoid sub-clavian vein if possible
Pediatric CRRT Vascular Access:
Performance = Blood Flow
 Minimum 30 to 50 ml/min to minimize access
and filter clotting
 Maximum rate of 400 ml/min/1.73m2 or
 10-12 ml/kg/min in neonates and infants
 4-6 ml/kg/min in children
 2-4 ml/kg/min in adolescents
Vascular Access
Two questions to be answered-
 What size catheter to use?
 Where to put it?
Femoral vs IJ catheter performance
 26 femoral
 19 > 20 cm
 7 < 20cm
 13 IJ
 Qb 250 ml/min (ultrasound dilution)
 Recirculation measurement by ultrasound
dilution method
Little et al: AJKD 36:1135-9, 2000
Femoral vs IJ catheter performance
Type Number
Qb
(ml/min)
Recirculation(%) 95% CI
Femoral 26 237.1 13.1* 7.6 to 18.6
> 20cm 19 233.3 8.5** 2.9 to 13.7
< 20cm 7 247.5 26.3**
17.1 to
35.5
Jugular 13 226.4 0.4* -0.1 to 1.0
Little et al: AJKD 36:1135-9, 2000
* p<0.001
** p<0.007
Vascular Access
ppCRRT Registry Access Study
 13 Pediatric Institutions
 376 patients
 1574 circuits
 Circuit survival by Catheter size, site, and modality
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
Figure 2: Mean Patient Weight vs Catheter Size
0
20
40
60
80
100
5 French 7 French 8 French 9 French 10 French 11.5
French
12.5
French
Catheter Size
Kg
Hackbarth R et al: IJAIO 30:1116-21, 2007
Number of Patients
% Survival at 60
hours 
Catheter Size*
5 6 0 (p <0.0000)
7 57 43 (p < 0.002)
8 65 55 (NS)
9 35 51 (p < 0.002)
10 46 53 (NS)
11.5 71 57 (NS)
12.5 64 60 (NS)
Insertion Site
Internal Jugular 58 60 (p < 0.05)
Subclavian 31 51 (NS)
Femoral 260 52 (NS)
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
Hackbarth R et al: IJAIO 30:1116-21, 2007
Shorter life span
for 7 and 9 French
catheters (p< 0.002)
1st 72 hrs of circuit
life only
Figure 1: Catheter Location by Size
0
10
20
30
40
50
60
70
80
90
100
5 French 7 French 8 French 9 French 10 French 11.5 French 12.5 French
Catheter Size
%
Femoral
IJ
Subclavian
Unknown
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
“Location, location, location!”
Femoral Vein
Pros:
 Accessible under almost any conditions
 Easier to maintain hemostasis
Cons:
 Potential for kinking
 More recirculation
 Thrombosis
 Problematic flow with increased abdominal pressures
Vascular Access
“Location, location, location!”
Subclavian Vein
Pros:
 Shorter catheter/better flow
 Less recirculation
Cons:
 Potential for kinking
 Difficult hemostasis
 Potential for venous narrowing
 Less accessible with cervical trauma
Vascular Access
“Location, location, location!”
Internal Jugular Vein
Pros:
 Shorter catheter/better flow
 Less recirculation
Cons:
 Difficult hemostasis
 Less accessible with cervical trauma
 Catheter length problematic in small infants
Number of Patients
% Survival at 60
hours 
Catheter Size*
5 6 0 (p <0.0000)
7 57 43 (p < 0.002)
8 65 55 (NS)
9 35 51 (p < 0.002)
10 46 53 (NS)
11.5 71 57 (NS)
12.5 64 60 (NS)
Insertion Site
Internal Jugular 58 60 (p < 0.05)
Subclavian 31 51 (NS)
Femoral 260 52 (NS)
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
Hackbarth R et al: IJAIO 30:1116-21, 2007
Survival favors IJ
Location (p< 0.05)
Vascular Access
Catheter proximity
 Inadvertent removal of infusions
 Circuit clotting with platelet transfusions
 Entraining calcium into the circuit
Vascular Access
Note the relationship of the line tips.
Vascular Access for Pediatric
CRRT
(Hackbarth et al, CRRT 2005)
 Children on CRRT/24 months
 Age range 2 days – 18 yrs
 Wt range 2.5-78 Kg
 Citrate anticoagulation
 Avg circuit life 3.1 days (0.3-11 days)
 Access was size dependent
 7 Fr dual lumen with clot in 50%
 Avg BFR 27 mls/min
 8 Fr dual lumen with clot in 20%
 Avg BFR 73 mls/min
 12 Fr triple lumen with no clot in any
 Avg BFR 127 mls/min
 This was used in in all children > 35 kg
Vascular Access for Pediatric
CRRT
(Hackbarth et al, CRRT 2005)
Triple vs Dual in Peds RRT
 5 year experience with Pediatric CRRT using
the “pigtail” as the CaCL replacement
 If not for citrate CRRT also serves as an
added central line for other med/TPN infusion
 What staff at bedside ever has sufficient
central access?
Vascular Access
What size catheter should we use?
 Don’t use a 5 French catheter.
 Choose the largest diameter that is safe for the child.
 Choose the smallest catheter that will achieve the
necessary flow easily.
 Choose the the minimum length to position the tip for
optimal flow.
 In the femoral position, longer catheters will minimize
recirculation
Vascular Access
Where should the catheter go?
 What sites are available?
 Are there anatomic or physiologic constraints?
 Which vessel is optimal for the catheter size?
 Is the patient coagulopathic?
 Consider patient mobility and risk of kinking.
 Is there elevated intra-abdominal pressure?
Vascular Access
Where should the catheter go?
Answer: Internal Jugular vein if possible
PATIENT SIZE CATHETER SIZE &
SOURCE
SITE OF INSERTION
NEONATE Single-lumen 5 Fr (COOK) Femoral artery or vein
Dual-Lumen 7.0 French
(COOK/MEDCOMP)
Femoral vein
3-6 KG Dual-Lumen 7.0 French
(COOK/MEDCOMP)
Internal/External-Jugular,
Subclavian or Femoral vein
Triple-Lumen 7.0 Fr
(MEDCOMP)
Internal/External-Jugular,
Subclavian or Femoral vein
6-30 KG Dual-Lumen 8.0 French
(KENDALL/ARROW)
Internal/External-Jugular,
Subclavian or Femoral vein
>15-KG Dual-Lumen 9.0 French
(MEDCOMP)
Internal/External-Jugular,
Subclavian or Femoral vein
>30 KG Dual-Lumen 10.0 French
(KENDALL, ARROW)
Internal/External-Jugular,
Subclavian or Femoral vein
>30 KG Triple-Lumen 12 French
(KENDALL/ ARROW)
Internal/External-Jugular,
Subclavian or Femoral vein

Mais conteúdo relacionado

Semelhante a 6008061.ppt

carotidarterystenting-181220042512.pdf
carotidarterystenting-181220042512.pdfcarotidarterystenting-181220042512.pdf
carotidarterystenting-181220042512.pdf
FrankyQ2
 
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Pedro Martinez-Clark, M.D.
 
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
TransUlnar approach -  our experience in nhf . Dr. Ashok DuttaTransUlnar approach -  our experience in nhf . Dr. Ashok Dutta
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
Ashok Dutta
 

Semelhante a 6008061.ppt (20)

non surgical intervention in tof.pptx
non surgical intervention in tof.pptxnon surgical intervention in tof.pptx
non surgical intervention in tof.pptx
 
J. frederick ctsa summit tavr
J. frederick   ctsa summit tavrJ. frederick   ctsa summit tavr
J. frederick ctsa summit tavr
 
PCI & AimRadial 2018 | Safety and Feasibility of Trans-radial Access for Non-...
PCI & AimRadial 2018 | Safety and Feasibility of Trans-radial Access for Non-...PCI & AimRadial 2018 | Safety and Feasibility of Trans-radial Access for Non-...
PCI & AimRadial 2018 | Safety and Feasibility of Trans-radial Access for Non-...
 
Percutaneous Drainage of Abscess and Post Operative Collections
Percutaneous Drainage of Abscess and Post Operative CollectionsPercutaneous Drainage of Abscess and Post Operative Collections
Percutaneous Drainage of Abscess and Post Operative Collections
 
carotidarterystenting-181220042512.pdf
carotidarterystenting-181220042512.pdfcarotidarterystenting-181220042512.pdf
carotidarterystenting-181220042512.pdf
 
Carotid artery stenting basics
Carotid artery stenting basicsCarotid artery stenting basics
Carotid artery stenting basics
 
TAVI
TAVI TAVI
TAVI
 
Laparoscopic Liver Resection : What to do and not do - Pr Daniel CHERQUI
Laparoscopic Liver Resection : What to do and not do - Pr Daniel CHERQUILaparoscopic Liver Resection : What to do and not do - Pr Daniel CHERQUI
Laparoscopic Liver Resection : What to do and not do - Pr Daniel CHERQUI
 
Peripheral Nerve Catheters - an introduction
Peripheral Nerve Catheters - an introductionPeripheral Nerve Catheters - an introduction
Peripheral Nerve Catheters - an introduction
 
Steam catheter
Steam catheterSteam catheter
Steam catheter
 
Yeh RW - Femoral vs radial: evidence - 201507
Yeh RW - Femoral vs radial: evidence - 201507Yeh RW - Femoral vs radial: evidence - 201507
Yeh RW - Femoral vs radial: evidence - 201507
 
1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal
 
Luc Rotenberg, Gregory Lenczner ULTRASOUND GUIDED VENOUS ACCESS CHEST PORT IM...
Luc Rotenberg, Gregory Lenczner ULTRASOUND GUIDED VENOUS ACCESS CHEST PORT IM...Luc Rotenberg, Gregory Lenczner ULTRASOUND GUIDED VENOUS ACCESS CHEST PORT IM...
Luc Rotenberg, Gregory Lenczner ULTRASOUND GUIDED VENOUS ACCESS CHEST PORT IM...
 
Cohen MG - Transradial access - 201507
Cohen MG - Transradial access - 201507Cohen MG - Transradial access - 201507
Cohen MG - Transradial access - 201507
 
Ivancev 2
Ivancev 2Ivancev 2
Ivancev 2
 
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
 
Hemodialysis procedure dr. mohamed kamal
Hemodialysis procedure   dr. mohamed kamalHemodialysis procedure   dr. mohamed kamal
Hemodialysis procedure dr. mohamed kamal
 
Dialysis access interventions
Dialysis access interventionsDialysis access interventions
Dialysis access interventions
 
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
TransUlnar approach -  our experience in nhf . Dr. Ashok DuttaTransUlnar approach -  our experience in nhf . Dr. Ashok Dutta
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
 
Specialized Dialysis & Vascular Access In Children
Specialized Dialysis & Vascular Access In ChildrenSpecialized Dialysis & Vascular Access In Children
Specialized Dialysis & Vascular Access In Children
 

Mais de anesthesia2023 (20)

3908843.ppt
3908843.ppt3908843.ppt
3908843.ppt
 
4484085.ppt
4484085.ppt4484085.ppt
4484085.ppt
 
How To Think Like A Programmer (1).pptx
How To Think Like A Programmer (1).pptxHow To Think Like A Programmer (1).pptx
How To Think Like A Programmer (1).pptx
 
16934165.ppt
16934165.ppt16934165.ppt
16934165.ppt
 
3913479.ppt
3913479.ppt3913479.ppt
3913479.ppt
 
13337238.ppt
13337238.ppt13337238.ppt
13337238.ppt
 
12572001.ppt
12572001.ppt12572001.ppt
12572001.ppt
 
6098714.ppt
6098714.ppt6098714.ppt
6098714.ppt
 
8323597.ppt
8323597.ppt8323597.ppt
8323597.ppt
 
12452550.ppt
12452550.ppt12452550.ppt
12452550.ppt
 
3936599.ppt
3936599.ppt3936599.ppt
3936599.ppt
 
14048227.ppt
14048227.ppt14048227.ppt
14048227.ppt
 
THROMBOLYTIC DRUGS.ppt
THROMBOLYTIC DRUGS.pptTHROMBOLYTIC DRUGS.ppt
THROMBOLYTIC DRUGS.ppt
 
9572195.ppt
9572195.ppt9572195.ppt
9572195.ppt
 
4556210.ppt
4556210.ppt4556210.ppt
4556210.ppt
 
17100493.ppt
17100493.ppt17100493.ppt
17100493.ppt
 
11780314.ppt
11780314.ppt11780314.ppt
11780314.ppt
 
10800669.ppt
10800669.ppt10800669.ppt
10800669.ppt
 
ANALYTICAL.ppt
ANALYTICAL.pptANALYTICAL.ppt
ANALYTICAL.ppt
 
presenation of Anaesthesia for laparoscopic surgery.pptx
presenation of Anaesthesia for laparoscopic surgery.pptxpresenation of Anaesthesia for laparoscopic surgery.pptx
presenation of Anaesthesia for laparoscopic surgery.pptx
 

Último

Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
Probe Gold
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
xzxvi5zp
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
Terna SpA
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
sovco
 

Último (20)

countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024
 
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdfITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
 
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In DubaiDubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
 
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your AreaGorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
 
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call GirlsPremium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
 
Teekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings PresentationTeekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings Presentation
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
 
Osisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 ResultsOsisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 Results
 
Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
 
SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024
 
AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024
 
Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024
 
Teekay Corporation Q1-24 Earnings Results
Teekay Corporation Q1-24 Earnings ResultsTeekay Corporation Q1-24 Earnings Results
Teekay Corporation Q1-24 Earnings Results
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
Western Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 PresentationWestern Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 Presentation
 

6008061.ppt

  • 1. Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his help and slides)
  • 2. Access  If you don’t have it you might as well go home.  This is the most important aspect of CRRT therapy.  Adequacy.  Filter life.  Increased blood loss.  Staff satisfaction.
  • 3. Vascular Access  Ideal Catheter Characteristics  Easy Insertion  Permits Adequate Blood Flow without Vessel Damage  Minimal Technical Flaws  High Recirculation Rate  Kinking  Shorter and Larger Catheters SIZE DOES MATTER  Lower Resistance  Improved Bloodflow
  • 4. Vascular Access for CRRT  Match catheter size to patient size and anatomical site  One dual- or triple-lumen or two single lumen uncuffed catheters  Sites  femoral  internal jugular  avoid sub-clavian vein if possible
  • 5. Pediatric CRRT Vascular Access: Performance = Blood Flow  Minimum 30 to 50 ml/min to minimize access and filter clotting  Maximum rate of 400 ml/min/1.73m2 or  10-12 ml/kg/min in neonates and infants  4-6 ml/kg/min in children  2-4 ml/kg/min in adolescents
  • 6. Vascular Access Two questions to be answered-  What size catheter to use?  Where to put it?
  • 7. Femoral vs IJ catheter performance  26 femoral  19 > 20 cm  7 < 20cm  13 IJ  Qb 250 ml/min (ultrasound dilution)  Recirculation measurement by ultrasound dilution method Little et al: AJKD 36:1135-9, 2000
  • 8. Femoral vs IJ catheter performance Type Number Qb (ml/min) Recirculation(%) 95% CI Femoral 26 237.1 13.1* 7.6 to 18.6 > 20cm 19 233.3 8.5** 2.9 to 13.7 < 20cm 7 247.5 26.3** 17.1 to 35.5 Jugular 13 226.4 0.4* -0.1 to 1.0 Little et al: AJKD 36:1135-9, 2000 * p<0.001 ** p<0.007
  • 9. Vascular Access ppCRRT Registry Access Study  13 Pediatric Institutions  376 patients  1574 circuits  Circuit survival by Catheter size, site, and modality Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 10. Vascular Access Figure 2: Mean Patient Weight vs Catheter Size 0 20 40 60 80 100 5 French 7 French 8 French 9 French 10 French 11.5 French 12.5 French Catheter Size Kg Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 11. Number of Patients % Survival at 60 hours  Catheter Size* 5 6 0 (p <0.0000) 7 57 43 (p < 0.002) 8 65 55 (NS) 9 35 51 (p < 0.002) 10 46 53 (NS) 11.5 71 57 (NS) 12.5 64 60 (NS) Insertion Site Internal Jugular 58 60 (p < 0.05) Subclavian 31 51 (NS) Femoral 260 52 (NS) Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 12. Vascular Access Hackbarth R et al: IJAIO 30:1116-21, 2007 Shorter life span for 7 and 9 French catheters (p< 0.002) 1st 72 hrs of circuit life only
  • 13. Figure 1: Catheter Location by Size 0 10 20 30 40 50 60 70 80 90 100 5 French 7 French 8 French 9 French 10 French 11.5 French 12.5 French Catheter Size % Femoral IJ Subclavian Unknown Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 14. Vascular Access “Location, location, location!” Femoral Vein Pros:  Accessible under almost any conditions  Easier to maintain hemostasis Cons:  Potential for kinking  More recirculation  Thrombosis  Problematic flow with increased abdominal pressures
  • 15. Vascular Access “Location, location, location!” Subclavian Vein Pros:  Shorter catheter/better flow  Less recirculation Cons:  Potential for kinking  Difficult hemostasis  Potential for venous narrowing  Less accessible with cervical trauma
  • 16. Vascular Access “Location, location, location!” Internal Jugular Vein Pros:  Shorter catheter/better flow  Less recirculation Cons:  Difficult hemostasis  Less accessible with cervical trauma  Catheter length problematic in small infants
  • 17. Number of Patients % Survival at 60 hours  Catheter Size* 5 6 0 (p <0.0000) 7 57 43 (p < 0.002) 8 65 55 (NS) 9 35 51 (p < 0.002) 10 46 53 (NS) 11.5 71 57 (NS) 12.5 64 60 (NS) Insertion Site Internal Jugular 58 60 (p < 0.05) Subclavian 31 51 (NS) Femoral 260 52 (NS) Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 18. Vascular Access Hackbarth R et al: IJAIO 30:1116-21, 2007 Survival favors IJ Location (p< 0.05)
  • 19. Vascular Access Catheter proximity  Inadvertent removal of infusions  Circuit clotting with platelet transfusions  Entraining calcium into the circuit
  • 20. Vascular Access Note the relationship of the line tips.
  • 21. Vascular Access for Pediatric CRRT (Hackbarth et al, CRRT 2005)  Children on CRRT/24 months  Age range 2 days – 18 yrs  Wt range 2.5-78 Kg  Citrate anticoagulation  Avg circuit life 3.1 days (0.3-11 days)  Access was size dependent
  • 22.  7 Fr dual lumen with clot in 50%  Avg BFR 27 mls/min  8 Fr dual lumen with clot in 20%  Avg BFR 73 mls/min  12 Fr triple lumen with no clot in any  Avg BFR 127 mls/min  This was used in in all children > 35 kg Vascular Access for Pediatric CRRT (Hackbarth et al, CRRT 2005)
  • 23. Triple vs Dual in Peds RRT  5 year experience with Pediatric CRRT using the “pigtail” as the CaCL replacement  If not for citrate CRRT also serves as an added central line for other med/TPN infusion  What staff at bedside ever has sufficient central access?
  • 24. Vascular Access What size catheter should we use?  Don’t use a 5 French catheter.  Choose the largest diameter that is safe for the child.  Choose the smallest catheter that will achieve the necessary flow easily.  Choose the the minimum length to position the tip for optimal flow.  In the femoral position, longer catheters will minimize recirculation
  • 25. Vascular Access Where should the catheter go?  What sites are available?  Are there anatomic or physiologic constraints?  Which vessel is optimal for the catheter size?  Is the patient coagulopathic?  Consider patient mobility and risk of kinking.  Is there elevated intra-abdominal pressure?
  • 26. Vascular Access Where should the catheter go? Answer: Internal Jugular vein if possible
  • 27. PATIENT SIZE CATHETER SIZE & SOURCE SITE OF INSERTION NEONATE Single-lumen 5 Fr (COOK) Femoral artery or vein Dual-Lumen 7.0 French (COOK/MEDCOMP) Femoral vein 3-6 KG Dual-Lumen 7.0 French (COOK/MEDCOMP) Internal/External-Jugular, Subclavian or Femoral vein Triple-Lumen 7.0 Fr (MEDCOMP) Internal/External-Jugular, Subclavian or Femoral vein 6-30 KG Dual-Lumen 8.0 French (KENDALL/ARROW) Internal/External-Jugular, Subclavian or Femoral vein >15-KG Dual-Lumen 9.0 French (MEDCOMP) Internal/External-Jugular, Subclavian or Femoral vein >30 KG Dual-Lumen 10.0 French (KENDALL, ARROW) Internal/External-Jugular, Subclavian or Femoral vein >30 KG Triple-Lumen 12 French (KENDALL/ ARROW) Internal/External-Jugular, Subclavian or Femoral vein